4.6 Article

Remote monitoring: a cost or an investment?

Journal

EUROPACE
Volume 13, Issue -, Pages II44-II48

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/europace/eur082

Keywords

Cost; Cost-effectiveness; Implantable cardiac defibrillator; Pacemaker; Remote monitoring

Funding

  1. University Hospital of Geneva
  2. Medtronic
  3. St-Jude Medical
  4. Boston Scientific
  5. Sorin
  6. University of Leuven
  7. Siemens Medical Solutions
  8. Biotronik
  9. St Jude Medical
  10. Boston Scientific Inc.

Ask authors/readers for more resources

Remote management of pacemakers and implantable defibrillators is being increasingly used in Europe, due to its potential to improve follow-up efficiency and patient outcome. However, this paradigm shift needs to be economically viable for it to be sustainable in the long term. This article covers the economic aspects of remote device management, and reviews the current evidence in this field.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available